HCPCS Codes Similar to A4673

HCPCS Codes Similar to “A4673” Code.
Extension line with easy lock connectors, used with dialysis

E0782 Infusion pump, implantable, non-programmable (includes all components, e.g., pump, catheter, connectors, etc.) Code added date: 19860101 Code effective date: 20030101 TXT \| PDF \| XML \| JSON	E0783 Infusion pump system, implantable, programmable (includes all components, e.g., pump, catheter, connectors, etc.) Code added date: 19950101 Code effective date: 19980101 TXT \| PDF \| XML \| JSON
E2313 Power wheelchair accessory, harness for upgrade to expandable controller, including all fasteners, connectors and mounting hardware, each Code added date: 20080101 Code effective date: 20140401 TXT \| PDF \| XML \| JSON	A4672 Drainage extension line, sterile, for dialysis, each Code added date: 20040101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON
G9313 Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason Code added date: 20140101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON	G9314 Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given Code added date: 20140101 Code effective date: 20140101 TXT \| PDF \| XML \| JSON
G9315 Amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis Code added date: 20140101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON	G9891 Mdpp session reported as a line-item on a claim for a payable mdpp expanded model (em) hcpcs code for a session furnished by the billing supplier under the mdpp expanded model and counting toward achievement of the attendance performance goal for the payable mdpp expanded model hcpcs code (this code is for reporting purposes only) Code added date: 20180401 Code effective date: 20180401 TXT \| PDF \| XML \| JSON
M1145 Most favored nation (mfn) model drug add-on amount, per dose, (do not bill with line items that have the jw modifier) Code added date: 20210101 Code effective date: 20220228 TXT \| PDF \| XML \| JSON	M1343 Patients who are at pam level 4 at baseline or patients who are flagged with extreme straight line response sets on the pam or with excessive missing responses Code added date: 20240101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
M1411 Currently on first-line immune checkpoint inhibitors without chemotherapy Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	M1412 Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
M1413 Patients who had a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	M1414 Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication) Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON